Search Results 3431-3440 of 26339 for oral

1. Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF) - Mayo Clinic

   ... (oral vs rectal vs both oral and rectal); (3) role of oral budesonide in patients mild-moderate UC; (4) comparative effectiveness and tolerability of rectal ...

2. Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Subjects With Hypoparathyroidism - Mayo Clinic

   History of hypoparathyroidism · Requirement for supplemental oral calcium treatment ≥ 1000 mg per day. · Requirement for active vitamin D therapy at a dose of ≥ ...

3. John A. Occhino, M.D., M.S. - Doctors and Medical Staff - Mayo Clinic

   Professional memberships · 2023 - present. Oral ExaminerAmerican Board of Obstetrics and Gynecology · 2023. JudgeAnn Harris Award Committee · 2023 - 2026. Chair ...

4. Head and neck cancers - Doctors and departments - Mayo Clinic

   Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

5. Infectious Diseases A-Z: FDA approves HPV vaccine for adults 27-45 - Mayo Clinic News Network

   HPV is a group of related viruses that can spread from intimate skin-to-skin contact, usually through vaginal, anal or oral sex with someone who is infected ...

6. Neuroendocrine tumors - Doctors and departments - Mayo Clinic

   ... Oral biopsy, Cancer, Head and neck cancer, Facial fracture, Osteoradionecrosis, Chondrosarcoma, Nasal and paranasal tumors, Thyroid cancer, Soft tissue ...

7. Lyme disease - Diagnosis and treatment - Mayo Clinic

   Learn about the symptoms, diagnosis and treatment of this common tick-borne illness.

8. Small bowel cancer - Doctors and departments - Mayo Clinic

   ... Oral biopsy, Cancer, Head and neck cancer, Facial fracture, Osteoradionecrosis, Chondrosarcoma, Nasal and paranasal tumors, Thyroid cancer, Soft tissue ...

9. Clinical trials - Oncology (Medical)

   ... orally twice daily (BID), or critozinib, 250 mg orally BID. Patients ... Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target ...

10. Neuroendocrine tumors - Doctors and departments - Mayo Clinic

    ... Oral biopsy, Cancer, Head and neck cancer, Facial fracture, Osteoradionecrosis, Chondrosarcoma, Nasal and paranasal tumors, Thyroid cancer, Soft tissue ...